Understanding the Scale of Fentanyl Exposure
A new study led by researchers at the University of California, Los Angeles (UCLA) has quantified the staggering daily opioid intake of people who use illicit fentanyl. Published in the peer-reviewed journal Drug and Alcohol Dependence, the study found that individuals in Los Angeles who regularly use illicit fentanyl consume quantities equivalent to nearly 9,000 mg of morphine per day. This level is hundreds of times higher than typical fentanyl doses used in hospital settings, highlighting a massive gap between clinical practice and street-level opioid use.
The research, conducted by Drug Checking Los Angeles—a public health program founded by Chelsea Shover, associate professor-in-residence at UCLA and senior author of the study—used real-world data to estimate fentanyl exposure. The team analyzed purity data from over 500 fentanyl samples collected between September 2023 and January 2026, combined with surveys of 47 regular fentanyl users. Using morphine milligram equivalence (MME), a standardized measure that allows comparison across different opioids, they calculated an average daily intake of 8,887 MME.
Implications for Addiction Treatment
These findings shed light on why many patients struggle with medications for opioid use disorder (MOUD), such as methadone or buprenorphine. While MOUD is highly effective in reducing overdose mortality, the rise of fentanyl as the dominant street opioid has led to reports of severe withdrawal symptoms and challenges in initiating or maintaining treatment. The study suggests that the extreme tolerance built from such high daily doses may be a key factor.
Lead author Morgan Godvin, who has personal experience with opioid use disorder, noted that the gap between clinical knowledge of pharmaceutical opioids and illicit opioids remains wide, despite years of public health focus on the latter. “We had been treating illicit opioid doses as a black box—an unknown quantity,” Godvin said. This study opens that box, revealing a level of exposure that far exceeds what current treatment protocols were designed to handle.
Methodology and Data Sources
The modeling study relied on multiple data sources to ensure accuracy. Fentanyl sample purity was obtained from Drug Checking Los Angeles, which tests street drugs for composition and contaminants. Surveys of 47 individuals who use fentanyl regularly provided self-reported consumption patterns. The researchers then applied MME conversion factors to estimate daily morphine-equivalent doses.
The average daily intake of 8,887 MME is dramatically higher than typical medical doses. For context, a standard hospital dose of fentanyl for pain management might be 100 micrograms, equivalent to about 10 mg of morphine. The study’s findings indicate that illicit users are consuming doses that are nearly 900 times that amount.
Public Health and Policy Implications
The study underscores the urgent need for treatment approaches that account for the high tolerance levels seen in illicit fentanyl users. Current MOUD protocols may require adjustment, such as higher starting doses or longer tapering periods, to effectively manage withdrawal and prevent relapse. Additionally, the findings highlight the importance of harm reduction strategies, including drug checking services and access to safe supply, to reduce overdose risks.
As fentanyl continues to dominate the illicit opioid market, understanding the true scale of exposure is critical for developing effective public health responses. The researchers call for further studies to replicate these findings in other regions and to explore tailored treatment interventions for this high-tolerance population.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
